Dutch Life Sciences Conference

07/12/23

10% discount for hollandbio members

Hollandbio members receive a 10% discount before October 1st. Contact hollandbio’s Max for more information.

Would you like to meet the Dutch Life Sciences & Health industry and explore business opportunities? Join more than 350 of our participants at the upcoming 19^th edition of the Dutch Life Sciences conference on December 7 at CORPUS Congress Centre at the Leiden Bio Science Park (Oegstgeest area).

Scaling up: through innovations, partnerships and business strategies

Dutch Life Sciences conference is Netherlands´ most established life sciences event. It has positioned itself as the premier annual meeting place for both Dutch and international players. The event brings together leading CEOs of biotech, pharma and medical devices companies, heads of R&D, academics, and life sciences investors from the healthcare sector for networking opportunities to promote the translation of inventions into e.g. therapies, medical devices and diagnostics distribution in and across the healthcare system. It provides a unique opportunity for discussions, panel presentations and product demonstrations and to meet new companies, paving the way for new business collaborations. The conference will discuss 8 main topics, where ‘Scaling up: through innovations, partnerships and business strategies’ will be a consistent underlying theme. Our esteemed speakers and thought leaders will explore the latest trends, cutting-edge technologies and disruptive business strategies that are reshaping the life sciences landscape. Together, let´s unlock the full potential of scaling up, shaping a healthier and more sustainable future for all.

Topics include:

• Women’s Health: challenges and opportunities
• Dealmaking for early-stage Life Sciences companies: licensing, valuations and deal structuring concepts and trends
• Artificial intelligence and the impact on product development and the product Life Cycle
• Innovation & Regulatory Challenges in Medical Devices
• Financing life sciences development and growth by M&A, IPO or partnering strategy
• Cell & Gene therapy: Innovations and business strategies

Check out the complete programme or register here.